Skip to main content
A Singapore Government Agency Website How to identify
Official website links end with .gov.sg
Government agencies communicate via .gov.sg websites (e.g. go.gov.sg/open). Trusted websites
Secure websites use HTTPS
Look for a lock () or https:// as an added precaution. Share sensitive information only on official, secure websites.

Government officials will never ask you to transfer money or disclose bank log-in details over a phone call.

Call the 24/7 ScamShield Helpline at 1799 if you are unsure if something is a scam.

National Drug Formulary

GLUCOSE INJECTION BP 50% [SIN06308P]

Active ingredients: GLUCOSE INJECTION BP 50%

View product's general information
Last updated 24 April 2026

Product Info

GLUCOSE INJECTION BP 50%

[SIN06308P]

Product information

Active Ingredient and Strength

GLUCOSE MONOHYDRATE - 55 G/100 ML

Dosage Form

INJECTION

Manufacturer and Country

B BRAUN MEDICAL INDUSTRIES SDN BHD - MALAYSIA

Registration Number

SIN06308P

Licence Holder

B. BRAUN SINGAPORE PTE LTD

Forensic Classification

GENERAL SALE LIST

Anatomical Therapeutic Chemical (ATC) code

B05BA03

Prescription-only Medicines with Exemptions for Supply without Prescription

NA

Indication

4.1 Therapeutic indications

Therapy of hypoglycaemia.

Dosing

4.2 Posology and method of administration

Posology
Adults
For the treatment of hypoglycaemia the dose and the administration rate have to be adjusted according to the actual blood glucose concentration and the general condition of the patient.

Fluid balance, serum glucose, and other electrolytes may need to be monitored before and during administration, especially in patients with increased non-osmotic vasopressin release (syndrome of inappropriate antidiuretic hormone secretion, SIADH) and in patients co-medicated with vasopressin agonist drugs due to the risk of hyponatraemia.

Monitoring of serum sodium is particularly important for physiologically hypotonic fluids. Glucose Injection BP 50% may become hypotonic after administration due to glucose metabolization in the body (see sections 4.4, 4.5 and 4.8 – please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information)

Paediatric population
For the treatment of hypoglycaemia the dose and the administration rate have to be adjusted according to the actual blood glucose concentration and the general condition of the patient.

For correction of hypoglycaemia in children, it is recommended to dilute the glucose concentrates to a strength not higher than 100 mg/ml.

Method of administration
Intravenous infusion or slow intravenous injection.

Glucose concentrates must be administered diluted as additive to infusion solutions. Hypertonic glucose solutions should be administered via a central venous catheter only.

Contraindications

4.3 Contraindications

  • Hypersensitivity to the active substance. See section 4.4 for corn allergies – please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information

  • Lactic acidosis